Advanced Filter

Filter by Group

Filter by Market Availability

Displaying all 12 drugs
Hepatitis B Vaccine is an ingredient in the EMA-withdrawn product Quintanrix. It is marketed in Canada as Engerix B. It is also a part of Twinrix (Hep A/Hep B vaccine) available also in Canada. The hepatitis B virus induces a severe form of viral hepatitis. Other causative agents are hepatitis...
Approved
Withdrawn
Matched Synonyms: … Hepatitis B virus hbsag surface protein antigen ... Hepatitis B surface antigen ... Hepatitis-B surface antigen
Matched Name: … Hepatitis B Vaccine (Recombinant) …
Matched Description: … It is estimated that the reservoir of persistent hepatitis B surface antigen carriers amounts to 350 ... Other causative agents are hepatitis A virus, and the non-A, non-B hepatitis viruses. ... Hepatitis D virus, a defective virus requiring the “keeper function” of the hepatitis B virus, occurs …
Matched Salts name: … Hepatitis B virus subtype ADW2 HBSAG surface protein antigen ... Hepatitis B virus subtype ADW HBSAG surface protein antigen
Matched Categories: … Inactivated Hepatitis B Virus Vaccine ... Hepatitis B Surface Antigens ... Hepatitis B Surface Antigens, drug effects ... Hepatitis B Antigens ... Hepatitis Antigens …
Matched Products: … Engerix-B ... Heplisav-B ... Engerix B Inj Sus 20mcg/ml …
Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml). 2. Live attenuated vaccines (based...
Approved
Matched Synonyms: … Hepatitis A vaccine, inactivated
Matched Name: … Hepatitis A Vaccine …
Matched Description: … Inactivated hepatitis A vaccines are safe and highly effective. ... Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. ... contracting hepatitis A and in immunocompromised individuals. …
Matched Salts name: … Hepatitis A virus strain HM175 antigen (formaldehyde inactivated) ... Hepatitis A virus strain CR 326F antigen (formaldehyde inactivated) …
Matched Categories: … Inactivated Hepatitis A Virus Vaccine …
Durvalumab is a a human monoclonal antibody that blocks programmed death ligand 1 (PD-L1), or CD 274. In May, 2017 it received FDA approval for previously treated patients with locally advanced or metastatic cancer in the urinary system (as Imfinzi). It is shown to be effective in patients with continued...
Approved
Investigational
Matched Description: … This drug has a relatively tolerable safety profile and its structural modification advantageously prevents ... Durvalumab is a a human monoclonal antibody that blocks programmed death ligand 1 (PD-L1), or CD 274. …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Antineoplastic and Immunomodulating Agents …
Avelumab is a programmed death ligand-1 (PD-L1) blocking antibody indicated for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC). It is a fully human anti-PD immunoglobulin G1 (IgG1) lambda monoclonal antibody with antineoplastic actions. It was granted accelerated approval in March...
Approved
Investigational
Matched Description: … and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC). ... Avelumab is a programmed death ligand-1 (PD-L1) blocking antibody indicated for the treatment of adults ... It is a fully human anti-PD immunoglobulin G1 (IgG1) lambda monoclonal antibody with antineoplastic actions …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Antineoplastic and Immunomodulating Agents …
Long-term hepatitis B immune globulin (HBIG) has been shown to reduce hepatitis B virus (HBV) reinfection in patients transplanted for hepatitis B. Infection with hepatitis B may lead to hepatocellular carcinoma, a type of liver cancer. Therefore, the hepatitis-B vaccines are cancer-preventing vaccines. According to the Centers for Disease Control...
Approved
Investigational
Matched Synonyms: … Human hepatitis B virus immune globulin ... Hepatitis B immune globulin human ... Hepatitis B Immune Globulin (Human) …
Matched Name: … Hepatitis B Immune Globulin …
Matched Description: … HBIG is prepared from the plasma of donors who have high antibody levels of the hepatitis B surface antigen ... Long-term hepatitis B immune globulin (HBIG) has been shown to reduce hepatitis B virus (HBV) reinfection ... Infection with hepatitis B may lead to hepatocellular carcinoma, a type of liver cancer. …
Matched Categories: … Virus Neutralization ... Amino Acids, Peptides, and Proteins …
Matched Products: … Hepatitis B Ig Inj ... HepaGam B ... Hyperhep B S/d …
Antihemophilic factor human, also known as Coagulation Factor VIII or Anti-Hemophilic Factor (AHF), is a non-recombinant, lyophilized concentrate of coagulation factor VIII, an endogenous protein and essential component of the coagulation cascade. Antihemophilic factor is manufactured with reduced amounts of von Willebrand Factor antigen (VWF:Ag) and purified from extraneous plasma-derived...
Approved
Matched Synonyms: … F8 protein, human …
Matched Description: … Factor VIII, but does not contain the B-domain, which has no known biological function and [DB11607] ... blood-borne diseases such as HIV and Hepatitis, which in part contributed to the Tainted Blood Scandal ... Antihemophilic factor is manufactured with reduced amounts of von Willebrand Factor antigen (VWF:Ag) …
Matched Categories: … Hemophilia A ... Blood and Blood Forming Organs ... Amino Acids, Peptides, and Proteins …
Galactose has been used in trials studying the treatment and diagnosis of Hepatitis C, Hepatic Cancer, Wilsons Disease, Diabetic Macular Oedema, and Focal Segmental Glomerulosclerosis, among others. There are even proposals for its use in accelerating senescence in mice, rats, and Drosophila, for its association with ovarian cancer, or even...
Approved
Investigational
Matched Description: … Galactose has been used in trials studying the treatment and diagnosis of Hepatitis C, Hepatic Cancer ... As a naturally occurring sugar, it may be found in a number dairy products. ... , Wilsons Disease, Diabetic Macular Oedema, and Focal Segmental Glomerulosclerosis, among others. …
PDPSC18 is therapeutic DNA vaccine designed to fight chronic infections with the Hepatitis B virus, entering phase I clinical trials.
Investigational
Matched Description: … PDPSC18 is therapeutic DNA vaccine designed to fight chronic infections with the Hepatitis B virus, entering …
XTL001 is an investigational monoclonal antibody (MAb) product developed by XTL Biopharmaceuticals to evaluate the safety profile and antiviral activity of the compound in patients chronically infected with hepatitis B virus (HBV).
Investigational
Matched International brands: … HepeX-B
Matched Description: … antiviral activity of the compound in patients chronically infected with hepatitis B virus (HBV). ... monoclonal antibody (MAb) product developed by XTL Biopharmaceuticals to evaluate the safety profile and
Matched Categories: … Amino Acids, Peptides, and Proteins …
GI-5005 is GlobeImmune's lead infectious disease product from its proprietary Tarmogen active immunotherapy platform for the treatment of chronic hepatitis C infection. GI-5005 is whole, heat-killed recombinant yeast genetically modified to express HCV-specific protein targets. Tarmogens are believed to activate both an innate immune response via Toll-like receptors (TLRs), as...
Investigational
Matched Description: … GI-5005 is whole, heat-killed recombinant yeast genetically modified to express HCV-specific protein ... disease product from its proprietary Tarmogen active immunotherapy platform for the treatment of chronic hepatitis ... to activate both an innate immune response via Toll-like receptors (TLRs), as well as an adaptive, antigen
Matched Categories: … Amino Acids, Peptides, and Proteins …
ISS 1018 is a short, synthetic, unmethylated CpG oligodeoxynucleotide (CpG ODN) with immunostimulatory activity. ISS 1018 signals through Toll-like receptor 9 (TLR9) to induce the production of immunoglobulin by B cells and interferon (IFN) -alpha, IFN-beta, interleukin-12 (IL-12), and tumor necrosis factor - alpha (TNF-alpha) by plasmacytoid dendritic cells (pDC)....
Investigational
Matched Description: … for to prevent Hepatitis B in adults. ... ISS 1018 is currently being investigated in combination with HBsAg vaccine as a prophylactic treatment ... ISS 1018 CpG ODN promotes antigen presentation and co-stimulatory molecule expression. …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
QS-21 is an investigational adjuvant, which is a substance added to vaccines and other immunotherapies that is designed to enhance the body’s immune response to the antigen contained within the treatment. It is the leading member of the Stimulon family of adjuvants. As a vaccine additive, it is currently being...
Investigational
Matched Description: … QS-21 is an investigational adjuvant, which is a substance added to vaccines and other immunotherapies ... that is designed to enhance the body’s immune response to the antigen contained within the treatment ... As a vaccine additive, it is currently being evaluated in clinical trials in a variety of disease areas …
Displaying all 12 drugs